These compounds may interact with:
RAC-beta serine/threonine-protein kinase
Potentially involved in: familial partial lipodystrophy; cancer; diabetes mellitus; carcinoma; obesity; acanthosis nigricans; bipolar disorder; diabetes mellitus, non-insulin-dependent; epilepsy; gynecomastia; hepatomegaly; insulin resistance; lipodystrophy; oligomenorrhea; polycystic ovary syndrome; seizures; neonatal hypoglycemia; obesity, abdominal; congenital hemihypertrophy; insulin resistant diabetes
Disease data sourced from Pharos.